Biosynthetic pathways of bioactive n-acylethanolamines in brain

CNS and Neurological Disorders - Drug Targets

Volumn 12, Issue 1, 2013, Pages 7-16

  Ueda, Natsuo ^a   Tsuboi, Kazuhito ^a   Ikematsu, Natsuki ^b   Uyama, Toru ^a   Deutsch, Dale G ^c   Tokumura, Akira ^b  

^a KAGAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

Anandamide; Biosynthesis; N acylethanolamine; Nape pld; Oleoylethanolamide; Palmitoylethanolamide; Phospholipid; Plasmalogen

Indexed keywords

ACYLTRANSFERASE; ANANDAMIDE; ENDOCANNABINOID; ETHANOLAMINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCEROPHOSPHOLIPID; GUANINE NUCLEOTIDE BINDING PROTEIN; LONG CHAIN FATTY ACID; MESSENGER RNA; N ACYLETHANOLAMINE; N OLEOYLETHANOLAMINE; PALMIDROL; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PLASMALOGEN; UNCLASSIFIED DRUG; VIRODHAMINE;

ARTICLE; BIOSYNTHESIS; DEACYLATION; HYDROLYSIS; INFLAMMATION; LIQUID CHROMATOGRAPHY; METABOLISM; NONHUMAN; POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY;

ANIMALS; BIOSYNTHETIC PATHWAYS; BRAIN; BRAIN CHEMISTRY; ETHANOLAMINES; HUMANS;

EID: 84875281731     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527311312010005     Document Type: Article

References (58)

1. Schmid, H.H.O.; Schmid, P.S.; Natarajan, V. N-Acylated glycerophospholipids and their derivatives. Prog. Lipid Res., 1990, 29, 1-43.
2. Hansen, H.S. Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain. Exp. Neurol., 2010, 224, 48-55.
3. LoVerme, J.; La Rana, G.; Russo, R.; Calignano, A.; Piomelli, D. The search for the palmitoylethanolamide receptor. Life Sci., 2005, 77, 1685-1698.
4. Petrosino, S.; Iuvone, T.; Di Marzo, V. N-Palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities. Biochimie, 2010, 92, 724-747.
5. Pavón, F.J.; Serrano, A.; Romero-Cuevas, M.; Alonso, M.; Rodríguez de Fonseca, F. Oleoylethanolamide: a new player in peripheral control of energy metabolism. Therapeutic implications. Drug Discov. Today: Disease Mechanisms, 2010, 7, e175-e183.
6. Fu, J.; Astarita, G.; Gaetani, S.; Kim, J.; Cravatt, B.F.; Mackie, K.; Piomelli, D. Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine. J. Biol. Chem., 2007, 282, 1518-1528.
7. Diep, T.A.; Madsen, A.N.; Holst, B.; Kristiansen, M.M.; Wellner, N.; Hansen, S.H.; Hansen, H.S. Dietary fat decreases intestinal levels of the anorectic lipids through a fat sensor. FASEB J., 2011, 25, 765-774.
8. Lucanic, M.; Held, J.M.; Vantipalli, M.C.; Klang, I.M.; Graham, J.B.; Gibson, B.W.; Lithgow, G.J.; Gill, M.S. N-Acylethanolamine signalling mediates the effect of diet on lifespan in Caenorhabditis elegans. Nature, 2011, 473, 226-229.
9. Pertwee, R.G.; Howlett, A.C.; Abood, M.E.; Alexander, S.P.; Di Marzo, V.; Elphick, M.R.; Greasley, P.J.; Hansen, H.S.; Kunos, G.; Mackie, K.; Mechoulam, R.; Ross, R.A. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol. Rev., 2010, 62, 588-631.
10. Starowicz, K.; Nigam, S.; Di Marzo, V. Biochemistry and pharmacology of endovanilloids. Pharmacol. Ther., 2007, 114, 13-33.
11. Pacher, P.; Bátkai, S.; Kunos, G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev., 2006, 58, 389-462.
12. Chávez, A.E.; Chiu, C.Q.; Castillo, P.E. TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus. Nat. Neurosci., 2010, 13, 1511-1518.
13. Grueter, B.A.; Brasnjo, G.; Malenka, R.C. Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens. Nat. Neurosci., 2010, 13, 1519-1525.
14. Ueda, N.; Tsuboi, K.; Uyama, T. Enzymological studies on the biosynthesis of N-acylethanolamines. Biochim. Biophys. Acta, 2010, 1801, 1274-1285.
15. Ueda, N.; Tsuboi, K.; Uyama, T. N-Acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA). Prog. Lipid Res., 2010, 49, 299-315.
16. Cravatt, B.F.; Giang, D.K.; Mayfield, S.P.; Boger, D.L.; Lerner, R.A.; Gilula, N.B. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature, 1996, 384, 83-87.
17. McKinney, M.K.; Cravatt, B.F. Structure and function of fatty acid amide hydrolase. Annu. Rev. Biochem., 2005, 74, 411-432.
18. Tsuboi, K.; Sun, Y.-X.; Okamoto, Y.; Araki, N.; Tonai, T.; Ueda, N. Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase. J. Biol. Chem., 2005, 280, 11082-11092.
19. Solorzano, C.; Zhu, C.; Battista, N.; Astarita, G.; Lodola, A.; Rivara, S.; Mor, M.; Russo R.; Maccarrone, M.; Antonietti, F.; Duranti, A.; Tontini, A.; Cuzzocrea, S.; Tarzia, G.; Piomelli, D. Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation. Proc. Natl. Acad. Sci. USA, 2009, 106, 20966-20971.
20. Ahn, K.; Smith, S.E.; Liimatta, M.B.; Beidler, D.; Sadagopan, N.; Dudley, D.T.; Young, T.; Wren, P.; Zhang, Y.; Swaney, S.; Van Becelaere, K.; Blankman, J.L.; Nomura, D.K.; Bhattachar, S.N.; Stiff, C.; Nomanbhoy, T.K.; Weerapana, E.; Johnson, D.S.; Cravatt, B.F. Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain. J. Pharmacol. Exp. Ther., 2011, 338, 114-124.
21. Okamoto, Y.; Morishita, J.; Tsuboi, K.; Tonai, T.; Ueda, N. Molecular characterization of a phospholipase D generating anandamide and its congeners. J. Biol. Chem., 2004, 279, 5298-5305.
22. Tsuboi, K.; Okamoto, Y.; Ikematsu, N.; Inoue, M.; Shimizu, Y.; Uyama, T.; Wang, J.; Deutsch, D.G.; Burns, M.P.; Ulloa, N.M.; Tokumura, A.; Ueda, N. Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and -independent pathways. Biochim. Biophys. Acta, 2011, 1811, 565-577.
23. Hansen, H.S.; Moesgaard, B.; Hansen, H.H.; Petersen, G. N-Acylethanolamines and precursor phospholipids - relation to cell injury. Chem. Phys. Lipids, 2000, 108, 135-150.
24. Cadas, H.; di Tomaso, E.; Piomelli D. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J. Neurosci., 1997, 17, 1226-1242.
25. 2+-independent phosphatidylethanolamine N-acyltransferase generating the anandamide precursor and its congeners. J. Biol. Chem., 2007, 282, 3614-3623.
26. Janfelt, C.; Wellner, N.; Leger, P.L.; Kokesch-Himmelreich, J.; Hansen, S.H.; Charriaut-Marlangue, C.; Hansen, H.S. Visualization by mass spectrometry of 2-dimensional changes in rat brain lipids, including N-acylphosphatidylethanolamines, during neonatal brain ischemia. FASEB J., 2012, 26, 2667-2673.
27. Uyama, T.; Jin, X.-H.; Tsuboi, K.; Tonai, T.; Ueda, N. Characterization of the human tumor suppressors TIG3 and HRASLS2 as phospholipid-metabolizing enzymes. Biochim. Biophys. Acta, 2009, 1791, 1114-1124.
28. Shinohara, N.; Uyama, T.; Jin, X.-H.; Tsuboi, K.; Tonai, T.; Houchi, H.; Ueda, N. Enzymological analysis of the tumor suppressor A-C1 reveals a novel group of phospholipid-metabolizing enzymes. J. Lipid Res., 2011, 52, 1927-1935.
29. Coulon, D.; Faure, L.; Salmon, M.; Wattelet, V.; Bessoule, J.J. N-Acylethanolamines and related compounds: aspects of metabolism and functions. Plant Sci., 2012, 184, 129-140.
30. Faure, L.; Coulon, D.; Laroche-Traineau, J.; Le Guedard, M.; Schmitter, J.M.; Testet, E.; Lessire, R.; Bessoule, J.J. Discovery and characterization of an Arabidopsis thaliana N-acylphosphatidylethanolamine synthase. J. Biol. Chem., 2009, 284, 18734-18741.
31. Bulat, E.; Garrett, T.A. Putative N-acylphosphatidylethanolamine synthase from Arabidopsis thaliana is a lysoglycerophospholipid acyltransferase. J. Biol. Chem., 2011, 286, 33819-33831.
32. Coulon, D.; Faure, L.; Salmon, M.; Wattelet, V.; Bessoule, J.J. Occurrence, biosynthesis and functions of N-acylphosphatidylethanolamines (NAPE): Not just precursors of N-acylethanolamines (NAE). Biochimie, 2012, 94, 75-85.
33. Gillum, M.P.; Zhang, D.; Zhang, X.M.; Erion, D.M.; Jamison, R.A.; Choi, C; Dong, J.; Shanabrough, M.; Duenas, H.R.; Frederick, D.W.; Hsiao, J.J.; Horvath, T.L.; Lo, CM.; Tso, P.; Cline, G.W.; Shulman, G.I. N-Acylphosphatidylethanolamine, a gut- derived circulating factor induced by fat ingestion, inhibits food intake. Cell, 2008, 135, 813-824.
34. Wellner, N.; Tsuboi, K.; Madsen, A.N.; Holst, B.; Diep, T.A.; Nakao, M.; Tokumura, A.; Burns, M.P.; Deutsch, D.G.; Ueda, N.; Hansen, H.S. Studies on the anorectic effect of N-acylphosphatidylethanolamine and phosphatidylethanolamine in mice. Biochim. Biophys. Acta, 2011, 1811, 508-512.
35. Wang, J.; Okamoto, Y.; Morishita, J.; Tsuboi, K.; Miyatake, A.; Ueda, N. Functional analysis of the purified anandamide-generating phospholipase D as a member of the metallo-beta-lactamase family. J. Biol. Chem., 2006, 281, 12325-12335.
36. Zhu, C; Solorzano, C; Sahar, S.; Realini, N.; Fung, E.; Sassone-Corsi, P.; Piomelli, D. Proinflammatory stimuli control N-acylphosphatidylethanolamine-specific phospholipase D expression in macrophages. Mol. Pharmacol, 2011, 79, 786-792.
37. Wangensteen, T.; Akselsen, H.; Holmen, J.; Undlien, D.; Retterstøl, L. A common haplotype in NAPEPLD is associated with severe obesity in a Norwegian population-based cohort (the HUNT study). Obesity (Silver Spring), 2011, 19, 612-617.
38. Kilaru, A.; Blancaflor, E.B.; Venables, B.J.; Tripathy, S.; Mysore, K.S.; Chapman, K.D. The N-acylethanolamine-mediated regulatory pathway in plants. Chem. Biodivers., 2007, 4, 1933-1955.
39. Natarajan, V.; Schmid, P.C.; Reddy, P.V.; Schmid, H.H.O. Catabolism of N-acylethanolamine phospholipids by dog brain preparations. J. Neurochem., 1984, 42, 1613-1619.
40. Sun, Y.-X.; Tsuboi, K.; Okamoto, Y.; Tonai, T.; Murakami, M.; Kudo, I.; Ueda, N. Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D. Biochem. J., 2004, 380, 749-756.
41. Leung, D.; Saghatelian, A.; Simon, G.M.; Cravatt, B.F. Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. Biochemistry, 2006, 45, 4720-4726.
42. Simon, G.M.; Cravatt, B.F. Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for a/p-hydrolase 4 in this pathway. J. Biol. Chem., 2006, 281, 26465-26472.
43. Simon, G.M.; Cravatt, B.F. Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain. J. Biol. Chem., 2008, 283, 9341-9349.
44. Liu, J.; Wang, L.; Harvey-White, J.; Osei-Hyiaman, D.; Razdan, R.; Gong, Q.; Chan, A.C.; Zhou, Z.; Huang, B.X.; Kim, H.Y.; Kunos, G. A biosynthetic pathway for anandamide. Proc. Natl. Acad. Sci. USA, 2006, 103, 13345-13350.
45. Liu, J.; Wang, L.; Harvey-White, J.; Huang, B.X.; Kim, H.Y.; Luquet, S.; Palmiter, R.D.; Krystal, G.; Rai, R.; Mahadevan, A.; Razdan, R.K.; Kunos, G. Multiple pathways involved in the biosynthesis of anandamide. Neuropharmacology, 2008, 54, 1-7.
46. Arreaza, G.; Devane, W.A.; Omeir, R.L.; Sajnani, G.; Kunz, J.; Cravatt, B.F.; Deutsch, D.G. The cloned rat hydrolytic enzyme responsible for the breakdown of anandamide also catalyzes its formation via the condensation of arachidonic acid and ethanolamine. Neurosci. Lett., 1997, 234, 59-62.
47. Katayama, K.; Ueda, N.; Katoh, I.; Yamamoto, S. Equilibrium in the hydrolysis and synthesis of cannabimimetic anandamide demonstrated by a purified enzyme. Biochim. Biophys. Acta, 1999, 1440, 205-214.
48. Mukhopadhyay, B.; Cinar, R.; Yin, S.; Liu, J.; Tam, J.; Godlewski, G.; Harvey-White, J.; Mordi, I.; Cravatt, B.F.; Lotersztajn, S.; Gao, B.; Yuan, Q.; Schuebel, K.; Goldman, D.; Kunos, G. Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver. Proc. Natl. Acad. Sci. USA, 2011, 108, 6323-6328.
49. McCue, J.M.; Driscoll, W.J.; Mueller, G.P. In vitro synthesis of arachidonoyl amino acids by cytochrome c. Prostaglandins Other Lipid Mediat., 2009, 90, 42-48.
50. Renault, L.; Nègre, V.; Hotelier, T.; Cousin, X.; Marchot, P.; Chatonnet, A. New friendly tools for users of ESTHER, the database of the a/p-hydrolase fold superfamily of proteins. Chem. Biol. Interact, 2005, 157-158, 339-343.
51. Zheng, B.; Chen, D.; Farquhar, M.G. MIR16, a putative membrane glycerophosphodiester phosphodiesterase, interacts with RGS16. Proc. Natl. Acad. Sci. USA, 2000, 97, 3999-4004.
52. Yanaka, N. Mammalian glycerophosphodiester phosphodiesterases. Biosci. Biotechnol. Biochem., 2007, 71, 1811-1818.
53. Zheng, B.; Berrie, C.P.; Corda, D.; Farquhar, M.G. GDE1/MIR16 is a glycerophosphoinositol phosphodiesterase regulated by stimulation of G protein-coupled receptors. Proc. Natl. Acad. Sci.USA, 2003, 100, 1745-1750.
54. Kopp, F.; Komatsu, T.; Nomura, D.K.; Trauger, S.A.; Thomas, J.R.; Siuzdak, G.; Simon, G.M.; Cravatt, B.F. The glycerophospho metabolome and its influence on amino acid homeostasis revealed by brain metabolomics of GDE1(-/-) mice. Chem. Biol, 2010, 17, 831-840.
55. Simon, G.M.; Cravatt, B.F. Characterization of mice lacking candidate N-acyl ethanolamine biosynthetic enzymes provides evidence for multiple pathways that contribute to endocannabinoid production in vivo. Mol. Biosyst, 2010, 6, 1411-1418.
56. Simpson, CD.; Hurren, R.; Kasimer, D.; MacLean, N.; Eberhard, Y.; Ketela, T.; Moffat, J.; Schimmer, A.D. A genome wide shRNA screen identifies a/p hydrolase domain containing 4 (ABHD4) as a novel regulator of anoikis resistance. Apoptosis, 2012, 17, 666-678.
57. Astarita, G.; Ahmed, F.; Piomelli, D. Identification of biosynthetic precursors for the endocannabinoid anandamide in the rat brain. J. Lipid Res., 2008, 49, 48-57.
58. Schmid, P.C.; Reddy, P.V.; Natarajan, V.; Schmid, H.H.O. Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type. J. Biol. Chem., 1983, 258, 9302-9306.